drugset / Trial / NCT05269017

Vitamin D Nasal Drops in Post COVID-19 Parosmia

NCT05269017

Phase 2 Unknown 60 enrolled Menoufia University
RandomizedParallel-groupSingle-blindTreatment

Summary

The current study will be a pilot study for a randomized controlled trial conducted on patients recruited from the outpatient clinic of the Otorhinolaryngology Department, Menoufia Faculty of Medicine To evaluate the effect of vitamin D nasal drops in the treatment of post COVID 19 parosmia

Timeline

Start
2022-06
Primary completion
2023-03
Completion
2023-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 64 ug Intranasal
Subject Cholecalciferol Other / unclassified 20000 iu Intranasal

Indications

No indication recorded.